Wells Fargo Maintains Overweight on CME Group, Raises Price Target to $315
Benzinga Newsdesk 2 weeks ago
Analyst RatingsNewsPrice TargetHot
Wells Fargo analyst Daniel Welden maintains CME Group (NASDAQ:CME) with a Overweight and raises the price target from $301 to $315.
Wells Fargo analyst Daniel Welden maintains CME Group (NASDAQ:CME) with a Overweight and raises the price target from $301 to $315.